Search Results

Patent Portfolios Protecting 10 Top-Selling Prescription Drugs.

• Authors : Horrow C; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Gabriele SME

Subjects: Patents as Topic* ; Prescription Drugs*/Prescription Drugs*/Prescription Drugs*/economics ; Drugs, Generic*/Drugs, Generic*/Drugs, Generic*/economics

• Source: JAMA internal medicine [JAMA Intern Med] 2024 Jul 01; Vol. 184 (7), pp. 810-817.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Gender and ethnic disparities in students' perceptions of how different groups of persons suspected of possessing and/or selling illegal drugs are treated in the criminal justice system.

• Authors : Carvajal MJ; Nova Southeastern University, Fort Lauderdale, Florida.; Twahir A

• Source: Journal of ethnicity in substance abuse [J Ethn Subst Abuse] 2023 May 04, pp. 1-13. Date of Electronic Publication: 2023 May 04.Publisher: Routledge Country of Publication: England NLM ID: 101083217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-2659

Record details

Websites Selling Controlled Drugs Without a Prescription.

• Authors : Rubin R

Subjects: Controlled Substances*/Controlled Substances*/Controlled Substances*/economics ; Drug Prescriptions* ; Internet*/Internet*/Internet*/economics

• Source: JAMA [JAMA] 2022 May 17; Vol. 327 (19), pp. 1860.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Online Pharmacies Selling Prescription Drugs: Systematic Review.

• Authors : Long CS; Faculty of Computing and Engineering, Quest International University, Ipoh 30250, Malaysia.; Kumaran H

• Source: Pharmacy (Basel, Switzerland) [Pharmacy (Basel)] 2022 Apr 01; Vol. 10 (2). Date of Electronic Publication: 2022 Apr 01.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101678532 Publication Model: Electronic Cited Medium: Internet ISSN: 2226-4787

Record details

Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.

• Authors : Chua KP; Kao-Ping Chua () is an assistant professor in the Department of Pediatrics and the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan Medical School, and an assistant professor in the Department of Health Management and Policy at the University of Michigan School of Public Health, both in Ann Arbor, Michigan.; Kimmel LE

Subjects: Drug Approval* ; Orphan Drug Production*; Costs and Cost Analysis

• Source: Health affairs (Project Hope) [Health Aff (Millwood)] 2021 Mar; Vol. 40 (3), pp. 453-460.Publisher: Project Hope Country of Publication: United States NLM ID: 8303128 Publication Model: Print Cited Medium: Internet ISSN: 1544-5208

Record details

Market Exclusivity Time for Top Selling Originator Drugs in Canada: A Cohort Study.

• Authors : Lexchin J; School of Health Policy and Management, York University, Toronto, Ontario, Canada. Electronic address: .

Subjects: Biological Products/Biological Products/Biological Products/*economics ; Commerce/Commerce/Commerce/*statistics & numerical data ; Drug Industry/Drug Industry/Drug Industry/*economics

• Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2017 Sep; Vol. 20 (8), pp. 1139-1142. Date of Electronic Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

End pharmacists' monopoly on selling certain drugs.

• Authors : Rutter P

Subjects: Community Pharmacy Services*/Community Pharmacy Services*/Community Pharmacy Services*/trends ; Nonprescription Drugs* ; Pharmacists*/Pharmacists*/Pharmacists*/statistics & numerical data

• Source: BMJ (Clinical research ed.) [BMJ] 2015 Jul 01; Vol. 351, pp. h3415. Date of Electronic Publication: 2015 Jul 01.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Variations in time of market exclusivity among top-selling prescription drugs in the United States.

• Authors : Wang B; The Program On Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Liu J

Subjects: Drug Industry*/Drug Industry*/Drug Industry*/economics ; Economic Competition* ; Health Care Sector*/Health Care Sector*/Health Care Sector*/economics

• Source: JAMA internal medicine [JAMA Intern Med] 2015 Apr; Vol. 175 (4), pp. 635-7.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.

• Authors : Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA. ; Franklin JM

Subjects: Consumer Product Safety* ; Developed Countries* ; Prescription Drugs*

• Source: BMJ quality & safety [BMJ Qual Saf] 2013 Sep; Vol. 22 (9), pp. 727-34. Date of Electronic Publication: 2013 Apr 25.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101546984 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The prevalence and cost of unapproved uses of top-selling orphan drugs.

• Authors : Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America. ; Myers JA

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/statistics & numerical data; Off-Label Use/Off-Label Use/Off-Label Use/*economics ; Orphan Drug Production/Orphan Drug Production/Orphan Drug Production/*economics

• Source: PloS one [PLoS One] 2012; Vol. 7 (2), pp. e31894. Date of Electronic Publication: 2012 Feb 21.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet

Record details